Skip to main content
Premium Trial:

Request an Annual Quote

Following Review, GTL Revises Goals, Scraps Funding Opportunities

NEW YORK, March 29 (GenomeWeb News) - The Department of Energy's Office of Science has restructured the facilities plan for its Genomics: Genomes to Life program in response to a review by the National Research Council of the National Academies.


The DOE said that rather than creating four separate facilities devoted specifically to protein production, biomolecular imaging, proteomics, and systems biology, as it had earlier planned, GTL now envisions "one or two vertically integrated centers with a focus on bioenergy research." However, it said that it could consider building centers for systems biology research into carbon sequestration and bioremediation in future years.

Additionally, the DOE said that it has cancelled its funding opportunity announcement for a planned GTL facility for the production and characterization of proteins and molecular tags, issued in early January. DOE said it plans to issue a new solicitation in the coming months for one or more centers for bioenergy research, and that bioenergy research has become an increasing priority for GTL.

DOE said that the new R&D plan "should be able to accomplish the GTL program's objectives more rapidly and at reduced cost."

The NRC recently recommended in a non-binding review that GTL uproot its R&D plan of creating four separate facilities devoted to specific genomic-related technologies in favor of building four vertically integrated facilities in which the four original disciplines would look for applications for tasks already identified as GTL targets.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.